Principia unveils technology, series A round

Principia BioPharma Inc. (South San Francisco, Calif.) unveiled details of its reversible covalent technology and said it received $12 million last year in the first tranche of a $36 million series A round. New Leaf Venture Partners; OrbiMed; Morgenthaler Ventures; SR One; and Mission Bay Capital participated. ...